Rubin; Mark A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rubin; Mark A..The latest application filed is for "systems and methods for detecting periodic patterns in large datasets".
Company Profile
5.26.25
- Rubin; Mark A. - Woburn MA
- Rubin; Mark A. - New York NY
- Rubin; Mark A. - Cambridge MA
- Rubin; Mark A. - Ann Arbor MI
- Rubin; Mark A. - Newton MA
Patent Activity
| Patent | Date |
|---|---|
| Systems And Methods For Detecting Periodic Patterns In Large Datasets App 20200234307 - Rubin; Mark A. ; et al. | 2020-07-23 |
| Recurrent SPOP mutations in prostate cancer Grant 10,443,102 - Rubin , et al. Oc | 2019-10-15 |
| NEAT1 as a prognostic marker and therapeutic target for prostate cancer Grant 10,294,476 - Chakravarty , et al. | 2019-05-21 |
| Systems And Methods For Detecting Periodic Patterns In Large Datasets App 20190114640 - RUBIN; MARK A. ; et al. | 2019-04-18 |
| Recurrent gene fusions in prostate cancer Grant 10,190,173 - Tomlins , et al. Ja | 2019-01-29 |
| Recurrent gene fusions in prostate cancer Grant 9,745,635 - Tomlins , et al. August 29, 2 | 2017-08-29 |
| ERG/TFF3/HMWCK triple immunostain for detection of prostate cancer Grant 9,678,077 - Rubin , et al. June 13, 2 | 2017-06-13 |
| Molecular subtyping, prognosis and treatment of prostate cancer Grant 9,568,483 - Rubin , et al. February 14, 2 | 2017-02-14 |
| Neat1 As A Prognostic Marker And Therapeutic Target For Prostate Cancer App 20170037408 - CHAKRAVARTY; Dimple ; et al. | 2017-02-09 |
| Recurrent Gene Fusions In Prostate Cancer App 20160319369 - Tomlins; Scott ; et al. | 2016-11-03 |
| Compositions and methods for diagnosing prostate cancer based on detection of SLC45A3-ELK4 fusion transcript Grant 9,458,213 - Rubin , et al. October 4, 2 | 2016-10-04 |
| Recurrent Gene Fusions In Prostate Cancer App 20160097104 - Tomlins; Scott ; et al. | 2016-04-07 |
| Recurrent gene fusions in prostate cancer Grant 9,284,609 - Tomlins , et al. March 15, 2 | 2016-03-15 |
| Methods of diagnosing and treating prostate cancer characterized by NDRG1-ERG fusion Grant 9,090,899 - Rubin , et al. July 28, 2 | 2015-07-28 |
| Erg/tff3/hmwck Triple Immunostain For Detection Of Prostate Cancer App 20150132767 - Rubin; Mark A. ; et al. | 2015-05-14 |
| MiRNA-31 AS A DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC AGENT IN CANCER App 20150104440 - Lin; Pei-Chun ; et al. | 2015-04-16 |
| Recurrent gene fusions in prostate cancer Grant 8,969,527 - Tomlins , et al. March 3, 2 | 2015-03-03 |
| Molecular Subtyping, Prognosis And Treatment Of Prostate Cancer App 20140037647 - Rubin; Mark A. ; et al. | 2014-02-06 |
| Recurrent Spop Mutations In Prostate Cancer App 20130331279 - Rubin; Mark A. ; et al. | 2013-12-12 |
| Recurrent gene fusions in prostate cancer Grant 8,580,509 - Tomlins , et al. November 12, 2 | 2013-11-12 |
| Recurrent Gene Fusions In Prostate Cancer App 20130040858 - Tomlins; Scott ; et al. | 2013-02-14 |
| Recurrent Gene Fusions In Prostate Cancer App 20120295809 - Tomlins; Scott ; et al. | 2012-11-22 |
| Recurrent Gene Fusions In Prostate Cancer App 20120296070 - Tomlins; Scott ; et al. | 2012-11-22 |
| Recurrent gene fusions in prostate cancer Grant 8,211,645 - Tomlins , et al. July 3, 2 | 2012-07-03 |
| Methods Of Diagnosing And Treating Prostate Cancer Characterized By Ndrg1-erg Fusion App 20120039889 - Rubin; Mark A. ; et al. | 2012-02-16 |
| Compositions And Methods For Diagnosing Prostate Cancer Based On Detection Of Slc45a3-elk4 Fusion Transcript App 20120039887 - Rubin; Mark A. ; et al. | 2012-02-16 |
| Methods for identifying and using SNP panels Grant 7,981,609 - Rubin , et al. July 19, 2 | 2011-07-19 |
| Recurrent Gene Fusions In Prostate Cancer App 20110034677 - Tomlins; Scott ; et al. | 2011-02-10 |
| Biomarkers for predicting prostate cancer progression Grant 7,803,552 - Rubin , et al. September 28, 2 | 2010-09-28 |
| Expression profile of prostate cancer Grant 7,767,393 - Chinnaiyan , et al. August 3, 2 | 2010-08-03 |
| Biomarkers For Predicting Prostate Cancer Progression App 20100137164 - Rubin; Mark A. ; et al. | 2010-06-03 |
| Recurrent gene fusions in prostate cancer Grant 7,718,369 - Tomlins , et al. May 18, 2 | 2010-05-18 |
| Biomarkers for predicting prostate cancer progression Grant 7,666,595 - Rubin , et al. February 23, 2 | 2010-02-23 |
| Methods for identifying and using SNP panels App 20090004652 - Rubin; Mark A. ; et al. | 2009-01-01 |
| Dectection of AMACR cancer markers in urine Grant 7,332,290 - Rubin , et al. February 19, 2 | 2008-02-19 |
| Recurrent gene fusions in prostate cancer App 20070212702 - Tomlins; Scott ; et al. | 2007-09-13 |
| Expression profile of prostate cancer Grant 7,229,774 - Chinnaiyan , et al. June 12, 2 | 2007-06-12 |
| Biomarkers for predicting prostate cancer progression App 20060234259 - Rubin; Mark A. ; et al. | 2006-10-19 |
| Expression profile of prostate cancer App 20060211017 - Chinnaiyan; Arul M. ; et al. | 2006-09-21 |
| AMACR cancer markers App 20050136493 - Rubin, Mark A. ; et al. | 2005-06-23 |
| Expression profile of prostate cancer App 20030175736 - Chinnaiyan, Arul M. ; et al. | 2003-09-18 |
Company Registrations
| NCAGE Code | 4ZPD5 | RUBIN, MARK A |
| CAGE Code | 4ZPD5 | RUBIN, MARK A |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 